Cardiac resynchronisation therapy benefits women more than men
WOMEN appear to benefit from cardiac resynchronisation therapy for heart failure more than men, it’s been shown for the first time.
A study analysed 1820 patients allocated to cardiac resynchronisation therapy with defibrillator (CRT-D) or implantable cardioverter-defibrillator. While males received significant benefit from CRT-D, females had a 69% reduction in death or heart failure and 72% reduction in all-cause mortality.
“These more favourable results for women were associated with consistently greater echocardiographic evidence of reverse cardiac remodelling in women than men,” researchers said.
J Am Coll Cardiol 2011;57:813-20